The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
PLGA-based nanoparticles: A new paradigm in biomedical applications
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Singh, A., Dilnawaz, F., Mewar, S., Sharma, U., Jagannathan, N. R., & Sahoo, S. K. (2011) · ACS Applied Materials & Interfaces · doi:10.1021/am101196v · Cited by 161
RetractedPoly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery Carrier
Makadia, H. K., & Siegel, S. J. (2011) · Polymers · doi:10.3390/polym3031377 · Cited by 4,816
PLGA-based nanoparticles: An overview of biomedical applications
Danhier, F., Ansorena, E., Silva, J. M., Coco, R., Le Breton, A., & Préat, V. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.01.043 · Cited by 3,806
Biodegradable polymeric nanoparticles based drug delivery systems
Kumari, A., Yadav, S. K., & Yadav, S. C. (2010) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2009.09.001 · Cited by 3,724
Biodegradable Long-Circulating Polymeric Nanospheres
Gref, R., Minamitake, Y., Peracchia, M. T., Trubetskoy, V., Torchilin, V., & Langer, R. (1994) · Science · doi:10.1126/science.8128245 · Cited by 2,920
Danhier, F., Feron, O., & Préat, V. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.08.027 · Cited by 2,800
Transplacental Carcinogenesis by Stilbestrol
Folkman, J. (1971) · New England Journal of Medicine · doi:10.1056/nejm197108122850711 · Cited by 2,640
Nanocapsule formation by interfacial polymer deposition following solvent displacement
Fessi, H., Puisieux, F., Devissaguet, J. P., Ammoury, N., & Benita, S. (1989) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(89)90281-0 · Cited by 2,288
Jain, R. A. (2000) · Biomaterials · doi:10.1016/s0142-9612(00)00115-0 · Cited by 2,214
(2016) · CRC Press eBooks · doi:10.1201/b12801 · Cited by 2,031
Polymer nanoparticles: Preparation techniques and size-control parameters
Rao, J. P., & Geckeler, K. E. (2011) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2011.01.001 · Cited by 1,725
Gref, R., Lück, M., Quellec, P., Marchand, M., Dellacherie, E., Harnisch, S., Blunk, T., & Müller, R. H. (2000) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/s0927-7765(99)00156-3 · Cited by 1,723
The mechanisms of drug release in poly(lactic-co-glycolic acid)-based drug delivery systems—A review
Fredenberg, S., Wahlgren, M., Reslow, M., & Axelsson, A. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.05.049 · Cited by 1,286
Imaging and drug delivery using theranostic nanoparticles
Janib, S. M., Moses, A. S., & MacKay, J. A. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.08.004 · Cited by 1,248
Polymers for the sustained release of proteins and other macromolecules
LANGER, R., & FOLKMAN, J. (1976) · Nature · doi:10.1038/263797a0 · Cited by 1,182
PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect
Acharya, S., & Sahoo, S. K. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.10.008 · Cited by 1,112
Govender, T. (1999) · Journal of Controlled Release · doi:10.1016/s0168-3659(98)00116-3 · Cited by 1,008
Dhar, S., Gu, F. X., Langer, R., Farokhzad, O. C., & Lippard, S. J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0809154105 · Cited by 994
PLGA Nanoparticles in Drug Delivery: The State of the Art;
Bala, I., Hariharan, S., & Kumar, M. R. (2004) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v21.i5.20 · Cited by 739
In vitro and in vivo degradation of porous poly(dl-lactic-co-glycolic acid) foams
Lu, L., Peter, S. J., D. Lyman, M., Lai, H.-L., Leite, S. M., Tamada, J. A., Uyama, S., Vacanti, J. P., Langer, R., & Mikos, A. G. (2000) · Biomaterials · doi:10.1016/s0142-9612(00)00047-8 · Cited by 668
Liu, Y., Miyoshi, H., & Nakamura, M. (2007) · International Journal of Cancer · doi:10.1002/ijc.22709 · Cited by 620
Paclitaxel-loaded PEGylated PLGA-based nanoparticles: In vitro and in vivo evaluation
Danhier, F., Lecouturier, N., Vroman, B., Jérôme, C., Marchand-Brynaert, J., Feron, O., & Préat, V. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.09.086 · Cited by 616
Effect of acidic pH on PLGA microsphere degradation and release
Zolnik, B. S., & Burgess, D. J. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.05.034 · Cited by 560
Mittal, G., Sahana, D. K., Bhardwaj, V., & Ravi Kumar, M. N. V. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.01.016 · Cited by 551
PLGA-Based Nanoparticles as Cancer Drug Delivery Systems
Tabatabaei Mirakabad, F. S., Nejati-Koshki, K., Akbarzadeh, A., Yamchi, M. R., Milani, M., Zarghami, N., Zeighamian, V., Rahimzadeh, A., Alimohammadi, S., Hanifehpour, Y., et al. (2014) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2014.15.2.517 · Cited by 542
Dunne, M., Corrigan, O. I., & Ramtoola, Z. (2000) · Biomaterials · doi:10.1016/s0142-9612(00)00040-5 · Cited by 444
Zhang, Z., & Feng, S.-S. (2006) · Biomaterials · doi:10.1016/j.biomaterials.2006.03.006 · Cited by 414
Nanovehicular Intracellular Delivery Systems
Prokop, A., & Davidson, J. M. (2008) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21270 · Cited by 363
Targeting of tumor endothelium by RGD-grafted PLGA-nanoparticles loaded with Paclitaxel
Danhier, F., Vroman, B., Lecouturier, N., Crokart, N., Pourcelle, V., Freichels, H., Jérôme, C., Marchand-Brynaert, J., Feron, O., & Préat, V. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.08.011 · Cited by 335
PEGylated PLGA-based nanoparticles targeting M cells for oral vaccination
Garinot, M., Fiévez, V., Pourcelle, V., Stoffelbach, F., des Rieux, A., Plapied, L., Theate, I., Freichels, H., Jérôme, C., Marchand-Brynaert, J., et al. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.04.021 · Cited by 331
MAO, S., XU, J., CAI, C., GERMERSHAUS, O., SCHAPER, A., & KISSEL, T. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.10.036 · Cited by 283
Nafee, N., Taetz, S., Schneider, M., Schaefer, U. F., & Lehr, C.-M. (2007) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2007.03.006 · Cited by 264
Pastorino, F., Brignole, C., Di Paolo, D., Nico, B., Pezzolo, A., Marimpietri, D., Pagnan, G., Piccardi, F., Cilli, M., Longhi, R., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-2117 · Cited by 232
Locatelli, E., & Comes Franchini, M. (2012) · Journal of Nanoparticle Research · doi:10.1007/s11051-012-1316-4 · Cited by 229
The Acidic Microclimate in Poly(lactide-co-glycolide) Microspheres Stabilizes Camptothecins
Shenderova, A., Burke, T. G., & Schwendeman, S. P. (1999) · Pharmaceutical Research · doi:10.1023/a:1018876308346 · Cited by 222
Dailey, L. A., Jekel, N., Fink, L., Gessler, T., Schmehl, T., Wittmar, M., Kissel, T., & Seeger, W. (2006) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2006.01.016 · Cited by 220
Concepts and practices used to develop functional PLGA-based nanoparticulate systems
Sah, H., Desu, Sah, Wood, & Thoma (2013) · International Journal of Nanomedicine · doi:10.2147/ijn.s40579 · Cited by 217
Effect of dose on the biodistribution and pharmacokinetics of PLGA and PLGA-mPEG nanoparticles
Panagi, Z., Beletsi, A., Evangelatos, G., Livaniou, E., Ithakissios, D. S., & Avgoustakis, K. (2001) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(01)00676-7 · Cited by 215
Effect of drug type on the degradation rate of PLGA matrices
SIEGEL, S., KAHN, J., METZGER, K., WINEY, K., WERNER, K., & DAN, N. (2006) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2006.06.009 · Cited by 208
Schliecker, G., Schmidt, C., Fuchs, S., & Kissel, T. (2003) · Biomaterials · doi:10.1016/s0142-9612(03)00243-6 · Cited by 208
Molecular imaging and therapy of atherosclerosis with targeted nanoparticles
Wickline, S. A., Neubauer, A. M., Winter, P. M., Caruthers, S. D., & Lanza, G. M. (2007) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.20866 · Cited by 201
Nanoparticulate systems for the delivery of antisense oligonucleotides
Lambert, G., Fattal, E., & Couvreur, P. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00116-2 · Cited by 201
A primer on the mechanics of P-glycoprotein the multidrug transporter
Hennessy, M., & Spiers, J. P. (2007) · Pharmacological Research · doi:10.1016/j.phrs.2006.10.007 · Cited by 199
Uskokovic, D., & Stevanovic, M. (2009) · Current Nanoscience · doi:10.2174/157341309787314566 · Cited by 182
Passerini, N., & Craig, D. Q. M. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00245-0 · Cited by 165
Esmaeili, F., Ghahremani, M. H., Esmaeili, B., Khoshayand, M. R., Atyabi, F., & Dinarvand, R. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.07.038 · Cited by 159
Lü, W., Tan, Y.-Z., Hu, K., & Jiang, X. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.01.043 · Cited by 156
PEGylation strategies for active targeting of PLA/PLGA nanoparticles
Betancourt, T., Byrne, J. D., Sunaryo, N., Crowder, S. W., Kadapakkam, M., Patel, S., Casciato, S. L., & Brannon‐Peppas, L. (2008) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.32247 · Cited by 155
Fast degrading polyesters as siRNA nano-carriers for pulmonary gene therapy
Nguyen, J., Steele, T. W. J., Merkel, O. M., Reul, R., & Kissel, T. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.06.010 · Cited by 147
Anticancer activity of cisplatin-loaded PLGA-mPEG nanoparticles on LNCaP prostate cancer cells
Gryparis, E. C., Hatziapostolou, M., Papadimitriou, Ε., & Avgoustakis, K. (2007) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2006.12.017 · Cited by 139
Wang, Y., Ng, Y. W., Chen, Y., Shuter, B., Yi, J., Ding, J., Wang, S., & Feng, S. (2008) · Advanced Functional Materials · doi:10.1002/adfm.200700456 · Cited by 123
Hua, F. J., Park, T. G., & Lee, D. S. (2003) · Polymer · doi:10.1016/s0032-3861(03)00025-9 · Cited by 121
Engineered PLGA Nanoparticles: An Emerging Delivery Tool in Cancer Therapeutics
Jain, A., Das, M., Swarnakar, N. K., & Jain, S. (2011) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v28.i1.10 · Cited by 121
Berchane, N. S., Carson, K. H., Rice-Ficht, A. C., & Andrews, M. J. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.12.037 · Cited by 108
Amann, L. C., Gandal, M. J., Lin, R., Liang, Y., & Siegel, S. J. (2010) · Pharmaceutical Research · doi:10.1007/s11095-010-0152-4 · Cited by 99
Preparation of poly( DL ‐lactide‐co‐glycolide) nanoparticles without surfactant
Jeong, Y., Cho, C., Kim, S., Ko, K., Kim, S., Shim, Y., & Nah, J. (2001) · Journal of Applied Polymer Science · doi:10.1002/app.1326 · Cited by 87
Oral bioavailability of docetaxel in combination with OC144-093 (ONT-093)
Kuppens, I. E. L. M., Bosch, T. M., van Maanen, M. J., Rosing, H., Fitzpatrick, A., Beijnen, J. H., & Schellens, J. H. M. (2004) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-004-0864-4 · Cited by 87
Nie, H., Lee, L. Y., Tong, H., & Wang, C. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.04.018 · Cited by 77
Murugesan, S., Mishra, P., & Jain, N. K. (2008) · Journal of drug targeting · doi:10.1080/10611860802088598 · Cited by 75
Pure Cellulose Nanoparticles from Trimethylsilyl Cellulose
Kostag, M., Köhler, S., Liebert, T. F., & Heinze, T. J. (2010) · Macromolecular Symposia · doi:10.1002/masy.200900095 · Cited by 71
Bypassing multidrug resistance in human breast cancer cells with lipid/polymer particle assemblies
Jin, Y., Li, Jin, Y., Xie, Yao, Li, & Qiu (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s27864 · Cited by 70
YANG, A., Yang, L., Liu, W., Li, Z., Xu, H. E., & Yang, X. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.09.015 · Cited by 69
Recent advances in PLGA particulate systems for drug delivery
Choi, J., Seo, K., & Yoo, J. (2012) · Journal of Pharmaceutical Investigation · doi:10.1007/s40005-012-0024-5 · Cited by 54
Kou, G., Gao, J., Wang, H., Chen, H., Li, B., Zhang, D., Wang, S., Hou, S., Qian, W., Dai, J., et al. (2007) · BMB Reports · doi:10.5483/bmbrep.2007.40.5.731 · Cited by 45
Gvili, K., Benny, O., Danino, D., & Marcelle, M. (2007) · Biopolymers · doi:10.1002/bip.20697 · Cited by 41
Preparation and Processing of Nanoscale Materials by Supercritical Fluid Technology
Rollins, H. W., Bunker, C. E., Sun, Y., Meziani, J., & Bandara, J. (2002) · CRC Press eBooks · doi:10.1201/9780203909362.ch13 · Cited by 25
Cited by
Elmowafy, E. M., Tiboni, M., & Soliman, M. E. (2019) · Journal of Pharmaceutical Investigation · doi:10.1007/s40005-019-00439-x · Cited by 621
PLGA-Based Nanoparticles in Cancer Treatment
Rezvantalab, S., Drude, N. I., Moraveji, M. K., Güvener, N., Koons, E. K., Shi, Y., Lammers, T., & Kiessling, F. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01260 · Cited by 607
Novel biomaterial strategies for controlled growth factor delivery for biomedical applications
Wang, Z., Wang, Z., Lu, W. W., Zhen, W., Yang, D., & Peng, S. (2017) · NPG Asia Materials · doi:10.1038/am.2017.171 · Cited by 446
PLGA-Based Composites for Various Biomedical Applications
Rocha, C. V., Gonçalves, V., da Silva, M. C., Bañobre-López, M., & Gallo, J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23042034 · Cited by 350
Cano, A., Ettcheto, M., Chang, J.-H., Barroso, E., Espina, M., Kühne, B. A., Barenys, M., Auladell, C., Folch, J., Souto, E. B., et al. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.03.010 · Cited by 337
Metadata
- Authors
- Sharma, S., Parmar, A., Kori, S., & Sandhir, R.
- Venue
- TrAC Trends in Analytical Chemistry
- Publisher
- Elsevier BV
- Published
- 2016-06
- Volume
- 80
- Pages
- 30-40
- ISSN
- 0165-9936 (ISSN-L)
- OpenAlex
- W2216824414
- Cited by
- 340
- References
- 66
- FWCI
- 5.06
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.